Beam Therapeutics Inc.
BEAM
$26.75
$0.240.91%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -20.11% | 12.93% | 370.38% | -16.61% | -12.18% |
| Total Depreciation and Amortization | -2.31% | 1.39% | 4.13% | 1.55% | -0.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 36.98% | -35.29% | -889.79% | 14.47% | -41.12% |
| Change in Net Operating Assets | 720.29% | -118.35% | -390.84% | 72.17% | 113.28% |
| Cash from Operations | 13.54% | -23.71% | -9.07% | 7.54% | 7.90% |
| Capital Expenditure | 23.02% | 27.18% | -25.72% | -217.76% | -59.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 95.54% | 122.54% | -13.24% | 169.24% | -287.00% |
| Cash from Investing | 94.21% | 120.20% | -14.15% | 165.83% | -294.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 578.36% | -99.25% | -45.24% | 14.49% | 362.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 578.36% | -79.59% | -45.24% | 32.73% | 733.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 72.15% | -102.72% | -49.39% | 77.24% | -5,422.76% |